News and Media

News and Media

Press Releases


June 28, 2017
Casebia Therapeutics names Robin A. Walker as Vice President, Head of Legal

May 11, 2017
Casebia Therapeutics Expands Leadership Team

March 14, 2017
CRISPR Therapeutics and Casebia Therapeutics Announce Commercial License Agreement with MaxCyte


November 1, 2016
Casebia Therapeutics Announces Appointment of James W. Burns, Ph.D. as President and Chief Executive Officer

Social Media

@casebiatx Mar 15
We are pleased to announce our license agreement for MaxCyte with CRISPR @CRISPRTX @MaxCyte_info

@casebiatx 16 Dec 2016
Congratulations to CRISPRTx on an important milestone!

See us on Twitter